Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultiva vs Conventional Sedatives for ICU Mechanical Ventilation
NCT00158873Phase 4Completed
- Sponsor
- GSK
- Start
- Sep 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remifentanil in sedation (2 arms), sponsored by GSK. Primary endpoint: Duration of time on mechanical ventilation. Started Sep 2004; status: completed.
02
Drugs
remifentanil
03
Conditions
sedation
Beyond the preview
Go deeper on NCT00158873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00158873.